Lanraplenib succinate (Standard)

Overview

Lanraplenib succinate (Standard) is the analytical standard of Lanraplenib (succinate) ( HY-109091B ). This product is intended for research and analytical applications. Lanraplenib succinate (GS-9876 succinate) is a highly selective and orally active SYK inhibitor (IC 50 =9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib succinate (GS-9876 succinate) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Syk

Product Information

• Catalog No.: HY-109091BR
• CAS No.: 1800047-00-0
• Molecular Formula: C23H25N9O.3/2C4H6O4
• Molecular Weight: 620.64
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source